United Kingdom · 
Who invested in LoQus23 Therapeutics?
LoQus23 Therapeutics's investors include Forbion Capital Partners, Novartis and SV Health Investors.
2023202420252026
$2.4MSeed$4.3MSeed$46MSeries A$20MSeries AUnited Kingdom · Series A startup
Who invested in LoQus23 Therapeutics
4 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 5 months ago
Funding summaryUpdated 26 Oct 2026
$73Mraised across 4 rounds since 2023, from 4 sources
$2.4MSeed$4.3MSeed$46MSeries A$20MSeries A
- Latest round
- Series A, $20MMay 2026
- Biggest round
- $46MSeries A · Oct 2024
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $2.4M Feb 2023
- Biggest round
- $46M Series A · Oct 2024
- Usual gap between rounds
- 15 months the median of 3
The rounds
- May 2026Series A$20M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Oct 2024
- Jul 2023Seed$4.3M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Feb 2023Seed$2.4M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about LoQus23 Therapeutics
How much has LoQus23 Therapeutics raised?
LoQus23 Therapeutics has raised $73M across 4 rounds since 2023.
When did LoQus23 Therapeutics last raise?
LoQus23 Therapeutics's most recent round was a Series A of $20M in May 2026.
What was LoQus23 Therapeutics's biggest round?
LoQus23 Therapeutics's largest round on record is $46M (Series A), in Oct 2024.
Who backed LoQus23 Therapeutics first?
LoQus23 Therapeutics's first round on record, in Oct 2024, was backed by Forbion Capital Partners, Novartis and SV Health Investors.
What stage is LoQus23 Therapeutics at?
LoQus23 Therapeutics's latest named round is a Series A, in May 2026.
Where is LoQus23 Therapeutics based?
LoQus23 Therapeutics is based in the United Kingdom.
Companies like LoQus23 Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.